Asia Pacific Veterinary Assistive Reproduction Technology Market Size & Share 2025 - 2034

Asia Pacific Veterinary Assistive Reproduction Technology Market Size

The Asia Pacific veterinary assistive reproduction technology market was estimated at USD 2.4 billion in 2024. The market is expected to grow from USD 2.5 billion in 2025 to USD 5.2 billion in 2034, at a CAGR of 8.6%, according to the latest report published by Global Market Insights Inc. The rise in demand for animal protein is one of the key drivers that has prompted widespread adoption of ART services in the veterinary field.

For instance, the Agricultural Outlook 2025–2034 projects a 6% increase in global per capita consumption of animal-source foods by 2034, with India and Southeast Asia driving 39% of global consumption growth. In order to meet this growing demand, methods such as artificial insemination, embryo transfer, and in vitro fertilization are becoming popular for increasing genetic quality and reproductive success rates in livestock animals.
 

Veterinary assistive reproductive technology (ART) is an advanced breeding approach used to enhance reproduction processes in animals by applying techniques such as artificial insemination (AI), in vitro fertilization (IVF), embryo transfer (ET), and related technologies. The leading market players in the Asia Pacific veterinary ART market include Genus Plc, CRV Holding B.V., URUS Group LP, SEMEX, and IMV Technologies. These players significantly influence the market by introducing advanced genetics, expanding ART service reach, and supplying state-of-the-art instruments and consumables, thereby driving productivity in the region’s animal agriculture industry.
 

From 2021 to 2023, the Asia-Pacific veterinary ART market witnessed steady growth, growing from USD 2 billion in 2021 to USD 2.2 billion in 2023, indicating a consistent upward trend. A key factor behind this growth was the growing need for high-quality animal protein, which fueled the adoption of ART methods to improve livestock productivity and genetic merit. Large-scale livestock-producing nations such as India and China widely adopted ART techniques such as AI and IVF to enhance breeding success and meet growing demand. In addition, supportive government policies in many Asia Pacific countries created a favorable climate for the market during this period.
 

Veterinary ART encompasses a range of medical procedures used to aid reproduction in animals. These technologies are essential in animal breeding, conservation of endangered species, and improving the genetics and health of livestock.
 

Asia Pacific Veterinary Assistive Reproduction Technology Market Trends

• Technological innovation continues to be a driving force behind market growth. Innovations in reproductive biotechnology, such as intracytoplasmic sperm injection (ICSI), cryopreservation of embryos, and precision ovum pick-up, are increasing reproductive success rates.
   
• Digital monitoring and AI-based reproductive diagnostics also enable veterinarians to accurately monitor animal fertility cycles, enhancing intervention timing and effectiveness. These innovations not only improve livestock efficiency but also facilitate targeted breeding programs for rare or threatened species, aiding biodiversity initiatives.
   
• Additionally, supportive government policies and schemes are boosting the adoption of ART across the region. National governments are increasingly financing livestock development projects, veterinary facilities, and ART-based research.
   
• The NLM aims to increase the productivity of livestock and the production of eggs, meat, goat milk, and wool, while also encouraging sustainable practices for the economic growth of farmers and rural communities.
   
• These policies lower the costs for breeders, enhance access to sophisticated reproductive technologies, and promote adoption among commercial farms and small-scale producers.
   
• Furthermore, rising consumer demand for high-quality meat, milk, and animal-derived products drives livestock breeders to adopt reproductive technologies that accelerate herd improvement. For example, in 2021, the Chinese consumed almost 100 million tons of meat, which was 27% of the world’s total and twice the total consumption in the U.S.
   
• Similarly, as per Statista, in 2024, the total domestic consumption volume of milk was over 210 million metric tons in India. This was an increase compared to the previous year, when the consumption volume was about 207 million metric tons.
   
• Thus, as demand continues to grow, livestock producers are increasing herd productivity and accelerating breeding cycles through the use of ART techniques.
   

Asia Pacific Veterinary Assistive Reproduction Technology Market Analysis

The Asia Pacific veterinary assistive reproduction technology market was valued at USD 2 billion and USD 2.1 billion in 2021 and 2022, respectively. The market size reached USD 2.4 billion in 2024, growing from USD 2.2 billion in 2023.
 

Based on the type, the market is segmented into services, semen, instruments, and kits and consumables. The kits and consumables segment held the largest market share of 39.7% in 2024 and is projected to grow at a CAGR of 8.7% between 2025 and 2034.
 

• The high adoption of artificial insemination (AI) and embryo transfer (ET) procedures requires the constant use of disposables such as pipettes, catheters, semen extenders, cryopreservation straws, and culture media.
   
• Unlike instruments, which represent a one-time investment, kits and consumables are needed in every procedure, creating recurring demand and driving segmental growth.
   
• In 2024, the semen segment accounted for the second-largest market share, valued at USD 773.3 million in veterinary assisted reproductive technology (ART) market, as it plays a central role in AI procedures across livestock species.
   
• Countries such as India, China, and Australia rely heavily on semen-based ART to enhance cattle genetics, boost milk yields, and improve reproductive efficiency in breeding programs.
   
• Compared with more advanced techniques such as in vitro fertilization (IVF) and embryo transfer, semen collection and insemination are cost-effective, less invasive, and more scalable in large herds.
   
• Additionally, the rising availability of high-quality, cryopreserved semen from superior sires is further reinforcing the growth of the semen segment.
   

Based on the technology, the Asia Pacific veterinary assistive reproduction technology market is categorized into artificial insemination (AI), in vitro fertilization (IVF), embryo transfer (MOET), and other technologies. The artificial insemination (AI) segment dominated the market and is anticipated to reach USD 4 billion by 2034.
 

• Artificial insemination (AI) is the most commonly used reproduction method for the enhancement of livestock in the region. Due to its relatively low price, simple process, and proven effectiveness, it is accessible to farmers across diverse economic settings.
   
• Additionally, government-backed breeding programs have further cemented AI’s dominance in the region. For instance, India's National Dairy Development Board (NDDB) plays a central role in promoting artificial insemination (AI) to improve dairy cattle genetics, increase milk production, and enhance farmer profitability.
   
• Furthermore, the cost-effectiveness, reliability, and low risk of injury or disease transmission compared to natural breeding are significant contributors to the AI segment’s market share.
   
• The in vitro fertilization (IVF) segment, on the other hand, is anticipated to witness robust growth at a CAGR of 9.6%.
   
• IVF offers the ability to generate multiple embryos from high-value donor females, significantly enhancing reproductive efficiency compared to traditional artificial insemination. Thus, the demand for advanced breeding solutions that deliver faster genetic improvement is driving the adoption of this technique.

Learn more about the key segments shaping this market

Download Free PDF

Based on animal type, the Asia Pacific veterinary assistive reproduction technology market is categorized into bovine, swine, ovine, caprine, equine, and other animal types. The bovine segment dominated the market with 53.9% market share in 2024.
 

• Countries such as India, China, and Australia are among the largest producers and consumers of dairy and beef, creating strong demand for advanced reproductive technologies to enhance herd productivity.
   
• For example, as per the Food and Agriculture Organization, India is the world's largest milk producer, with 22% of global production, followed by the U.S., Pakistan, China, and Brazil.
   
• Additionally, growing support from government entities in prominent cattle-raising countries has supported reproduction technology adoption, thereby further driving segmental growth.
   
• For example, Rashtriya Gokul Mission (RGM), launched in 2014, is India’s government program for the development and conservation of indigenous cattle and buffalo breeds, aiming to enhance milk production, improve dairy farming profitability for farmers, and increase the availability of milk through advanced breeding technologies and artificial insemination. Such initiatives boost the adoption of ARTs in the bovine segment, thus cementing its dominant position.
   
• The swine segment held the second-largest market share of 21.9% in 2024 in the Asia Pacific veterinary assistive reproduction technology market, led by the high pork production base in China, Vietnam, and the Philippines, where pork is a major protein staple.
   
• For example, China is the world's largest producer and consumer of pork, with its production reaching around 57.06 million metric tons in 2024.
   

Based on the end use, the Asia Pacific veterinary assistive reproduction technology market is classified into veterinary clinics and hospitals, animal breeding centers, research institutes and universities, and other end users. In 2024, the veterinary clinics and hospitals segment held the highest market share and is expected to showcase growth at an 8.3% CAGR over the analysis period.
 

• Veterinary clinics and hospitals have a strong market share in the Asia Pacific veterinary ART market as they are the first point of contact for specialized reproductive services for livestock.
   
• These facilities are equipped with trained veterinarians, diagnostic tools, and ART-specific infrastructure, making them the preferred choice for farmers seeking reliable artificial insemination, embryo transfer, and IVF procedures.
   
• Further, their established infrastructure and ability to offer comprehensive care position them as key contributors to the market's dominance in this segment.

China's veterinary assistive reproduction technology market was valued at USD 637.3 million and USD 667.3 million in 2021 and 2022, respectively. The market size reached USD 740 million in 2024, growing from USD 701.4 million in 2023.
 

• China dominates the Asia Pacific veterinary ART market owing to its enormous livestock population and increasing demand for dairy products and meat.
   
• In 2023, Chinese cattle farms had an estimated livestock of around 73.56 million head of cattle, 5.3 billion chickens, and 434 million pigs.
   
• Further, as per Statista, in 2023, the Chinese population consumed on average 13.2 kilograms of milk and dairy products per person. Thus, such high demand increases the adoption of veterinary ART to boost domestic production.
   
• Additionally, government-driven breeding programs and policies further boost market growth.
   

India is experiencing rapid growth in the Asia Pacific veterinary ART market due to its large cattle base and the government's emphasis on enhancing dairy productivity.
 

• As the world’s largest milk producer, India faces growing demand for genetic improvement programs to enhance yield, fertility, and disease resistance in indigenous breeds.
   
• Several government initiatives, such as the National Dairy Plan and Rashtriya Gokul Mission play a crucial role in promoting ART adoption across rural and urban dairy farming systems.
   

Australia is anticipated to witness considerable growth in the Asia Pacific veterinary ART market.
 

• The market growth is supported by the country’s strong livestock industry, particularly in beef and dairy cattle. For instance, as per the Australian Bureau of Statistics, as of June 30, 2023, there were approximately 29.9 million cattle in Australia. This total includes 27.8 million beef cattle and 2.1 million dairy cattle.
   
• Additionally, the country is a leading exporter of beef globally, which creates continuous demand for advanced breeding technologies to improve herd genetics, fertility rates, and productivity.
   
• Further, the widespread awareness concerning the veterinary healthcare industry, along with the well-established veterinary infrastructure within the country, is increasing the demand for veterinary ART services.
   

Asia Pacific Veterinary Assistive Reproduction Technology Market Share

The market is highly competitive, with the presence of both established players, emerging companies, and several local and regional players focusing on innovation and technological advancements. The top 5 market players in the Asia Pacific veterinary ART market, including Genus Plc, CRV Holding B.V., URUS Group LP, SEMEX, and IMV Technologies, account for ~50% - 55% of the market. These industry players are noted to have undertaken certain strategic initiatives, such as product launches and approvals, assisting them in sustaining the market competition.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies, such as mergers, acquisitions, and novel product launches, to expand their product offerings.
 

Asia Pacific Veterinary Assistive Reproduction Technology Market Companies

Few of the prominent players operating in the Asia Pacific veterinary assistive reproduction technology industry include:

• AI Vet Services  
• Bovine Elite
• CRV Holdings B.V.
• Geno SA
• Genus Plc
• LIC
• Minitube Group
• SEMEX
• Select Sires
• Swine Genetics International
• STgenetics
• URUS Group LP
• VikingGenetics

• Genus Plc

Genus plc holds a strong position in the Asia Pacific veterinary ART market with a market share of ~22.5%. The company specializes in advanced breeding technologies for dairy, beef, and pork sectors. Operating through its subsidiaries Genus ABS (bovine genetics) and Genus PIC (porcine genetics), the company offers artificial insemination (AI), genomic testing, and reproductive services. The company serves over 85 countries and is recognized for its innovative approach to breeding and reproductive technologies.
 

• CRV Holding

CRV Holding is a Dutch cooperative specializing in cattle improvement, offering a comprehensive range of reproductive and genetic services. The company provides artificial insemination, embryo transfer, genomic testing, and herd management solutions. CRV's breeding programs focus on enhancing health, efficiency, and sustainability in dairy and beef herds. The company emphasizes innovation and animal welfare in its breeding strategies.
 

• URUS Group

URUS Group comprises of leading animal genetics and reproductive technology brands such as Alta Genetics, GENEX, and Trans Ova Genetics. The group offers a wide array of services, including artificial insemination, embryo transfer, in vitro fertilization, and genetic preservation. URUS focuses on providing sustainable and productive solutions for dairy and beef producers worldwide. Through its subsidiaries, URUS delivers advanced genetics, herd management tools, and reproductive services, playing a pivotal role in enhancing livestock productivity and genetic quality.
 

Asia Pacific Veterinary Assistive Reproduction Technology Industry News:

• In February 2025, Geno launched a campaign showcasing Norwegian Red cattle and the impact of AI and ET in improving fertility and sustainability. This highlighted advancements in the veterinary assistive reproduction technology market.
   
• In November 2024, CRV Holding B.V. launched a subsidiary in China, expanding its global footprint in the dairy market. The move enhances access to advanced genetic solutions and veterinary assistive reproduction technologies, supporting Chinese dairy farmers with sustainable and efficient breeding innovations.
   
• In 2023, URUS Group LP formed a joint venture with Genetics Australia Cooperative, creating Genetics Australia Holdings Pty Ltd. This collaboration integrates global R&D expertise, offering premium reproductive products and services under the Genetics Australia and Total Livestock Genetics brands.
   

The Asia Pacific veterinary assistive reproduction technology market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Services
• Semen
  • Normal semen
  • Sexed semen
• Instruments
• Kit and consumables

Market, By Technology

• Artificial insemination (AI)
• In vitro fertilization (IVF)
• Embryo transfer (MOET)
• Other technologies

Market, By Animal Type

• Bovine
• Swine
• Ovine
• Caprine
• Equine
• Other animal types

Market, By End Use

• Veterinary clinics and hospitals
• Animal breeding centers
• Research institutes and universities
• Other end use

The above information is provided for the following countries:

• China
• Japan
• India
• Australia
• South Korea
• Indonesia
• Malaysia
• Thailand
• Singapore
• Vietnam